Perceptive Advisors’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $9.43M | Sell |
|
|||||
|
2024
Q3 | $37M | Sell |
|
|||||
|
2024
Q2 | $66.1M | Hold |
|
|||||
|
2024
Q1 | $69.1M | Buy |
|
|||||
|
2023
Q4 | $44.7M | Sell |
|
|||||
|
2023
Q3 | $37.6M | Sell |
|
|||||
|
2023
Q2 | $35.1M | Sell |
|
|||||
|
2023
Q1 | $57.1M | Sell |
|
|||||
|
2022
Q4 | $73.9M | Sell |
|
|||||
|
2022
Q3 | $105M | Hold |
|
|||||
|
2022
Q2 | $99.2M | Buy |
|
|||||
|
2022
Q1 | $113M | Hold |
|
|||||
|
2021
Q4 | $147M | Buy |
|
|||||
|
2021
Q3 | $83.4M | Hold |
|
|||||
|
2021
Q2 | $74.7M | Buy |
|
|||||
|
2021
Q1 | $51.6M | Hold |
|
|||||
|
2020
Q4 | $51.6M | Hold |
|
|||||
|
2020
Q3 | $57.3M | Hold |
|
|||||
|
2020
Q2 | $59.2M | Buy |
|
|||||
|
2020
Q1 | $38M | Hold |
|
|||||
|
2019
Q4 | $64.9M | Hold |
|
|||||
|
2019
Q3 | $38.9M | Hold |
|
|||||
|
2019
Q2 | $64.7M | Hold |
|
|||||
|
2019
Q1 | $58.9M | Hold |
|
|||||
|
2018
Q4 | $77.6M | Hold |
|
|||||
|
2018
Q3 | $74.1M | Buy |
|